Medidata was recognised with the Asia Pacific (APAC) Clinical Trial IT Solutions Provider of the Year Award at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet in Singapore.
“Medidata is a prominent participant in the clinical trials IT solutions market, providing integrated solutions for clinical trial data management through a cloud-based unified platform with pioneering analytics,” said Aarti Chitale, senior research analyst at Frost & Sullivan.
The provider applies artificial intelligence and advanced analytics to deliver insights to over 1,100 customers across every therapeutic area and clinical phase, with a customer base ranging from emerging biotech to more established pharmaceutical and contract research organisations (CRO).
"The company's machine learning algorithm and a complete suite of services enable robust financial performance and elevate it to a leading technology solution provider in the clinical trial industry,” added Chitale.
“By adopting a collaborative business model, Medidata is establishing itself as a vital player in the global clinical trial IT market."
The recipients of the annual Frost & Sullivan APAC Best Practice Awards were identified based on in-depth research conducted by the its analysts.
The award categories offered each year are reviewed and evaluated to reflect the current market landscape and include new emerging trends.
The short-listed companies were evaluated on a variety of actual market performance indicators which include revenue growth; market share and growth in market share; leadership in product innovation; marketing strategy and business development strategy.
“We are proud to be named the 2018 Asia Pacific Clinical Trial IT Solutions Provider of the Year by Frost & Sullivan,” said Julie Iskow, executive vice president of product development and CTO, Medidata.
“This award recognises our commitment to accelerating the delivery of new therapies to patients around the world."